相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。\FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models
Guadalupe Vidal-Martinez et al.
EXPERIMENTAL NEUROLOGY (2020)
Exploring the putative role of kallikrein-6, calpain-1 and cathepsin-D in the proteolytic degradation of α-synuclein in multiple system atrophy
A. P. Kiely et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2019)
Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: A systematic review and meta-analysis
Farzaneh Rahmani et al.
BRAIN RESEARCH (2019)
Peripheral BDNF/TrkB protein expression is decreased in Parkinson's disease but not in Essential tremor
Yixian Huang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2019)
Serum miR-30c-5p is a potential biomarker for multiple system atrophy
Annamaria Vallelunga et al.
MOLECULAR BIOLOGY REPORTS (2019)
Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease
Sophie Virachit et al.
BRAIN PATHOLOGY (2019)
Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy
Taeyeon Kim et al.
MOLECULAR NEUROBIOLOGY (2019)
BACE1 inhibition more effectively suppresses initiation than progression of beta-amyloid pathology
Finn Peters et al.
ACTA NEUROPATHOLOGICA (2018)
MicroRNAs to differentiate Parkinsonian disorders: Advances in biomarkers and therapeutics
Palaniswamy Ramaswamy et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
AMBRA1, a novel -synuclein-binding protein, is implicated in the pathogenesis of multiple system atrophy
Yasuo Miki et al.
BRAIN PATHOLOGY (2018)
Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
Subodh Kumar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs
Jaynish S. Shah et al.
PLOS ONE (2016)
Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications
Simon Schafferer et al.
PLOS ONE (2016)
Cerebrospinal Fluid Peptides as Potential Parkinson Disease Biomarkers: A Staged Pipeline for Discovery and Validation
Min Shi et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative
Brice Laurens et al.
NEUROBIOLOGY OF DISEASE (2015)
Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population
Johannes Lange et al.
PARKINSONS DISEASE (2015)
Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96
Kiren Ubhi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2014)
MicroRNA-339-5p Down-regulates Protein Expression of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 (BACE1) in Human Primary Brain Cultures and Is Reduced in Brain Tissue Specimens of Alzheimer Disease Subjects*
Justin M. Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The MTHFR C677T polymorphism modifies age at onset in Parkinson's disease
Annamaria Vallelunga et al.
NEUROLOGICAL SCIENCES (2014)
CSF Aβ42 predicts early-onset dementia in Parkinson disease
Guido Alves et al.
NEUROLOGY (2014)
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy
Annamaria Vallelunga et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Cerebrospinal fluid A levels correlate with structural brain changes in Parkinson's disease
Mona K. Beyer et al.
MOVEMENT DISORDERS (2013)
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
Ju-Hee Kang et al.
JAMA NEUROLOGY (2013)
Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors
Kiren Ubhi et al.
JOURNAL OF NEUROSCIENCE (2010)
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman et al.
NEUROLOGY (2008)
Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases
S Lorenzl et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Selective loss of expression of glutamate GluR2/R3 receptor subunits in cerebellar tissue from a patient with olivopontocerebellar atrophy
G Dirson et al.
METABOLIC BRAIN DISEASE (2002)
分享论文
